CLINICAL NUCLEAR MEDICINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2248196, encodeId=f050224819611, content=这破杂志24年7月投的under Review 5个月没消息，第一次催稿邮件估计直接进了垃圾箱，第二次才回知道在个某个华人编辑手上，圣诞节前才给的拒稿，你猜拒稿理由人家漂亮国不用这个药而且最近有类似文章接受了？？！其他只字未提，真恶心人。。。。这杂志分数虚高都是些case，编辑不负责，建议绕道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=618e8608174, createdName=ms4000001428066077, createdTime=Wed Jan 15 16:02:15 CST 2025, time=2025-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=902336, encodeId=bac2902336c6, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：临床;核医学 经验分享：1. 更新下准确的影像因子，杂志官网可查到，2018年为6.709，2019为6.622。 2.老牌权威的核医学杂志。 3.近几年审稿速度比较快，一般不超过1个月，算审稿速度非常快的杂志了。 4.杂志的编辑很nice，但是很严谨。case report，只要图片和病例足够新颖，可以尝试，并不太难。论著有一定难度。 5.很临床的杂志，基础的文章不太收。 5.很多case report只在CNM发表，所以自引率比别的杂志高点可以理解。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rQvUN1zHBrywpiakiasoLOFr2w6FAZpJ4k6VRQsprf74lUTXZiavoSUjuLa18Igfbrx8amqbYTJXMVHbVtJOLq3vg/132, createdBy=8bbe1657894, createdName=丹子笑, createdTime=Thu Nov 26 00:17:50 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509212, encodeId=9f5a50921228, content=审稿速度:1.0 经验分享：才四天Decision in Process 什么意思呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=caed1611946, createdName=lanseyouyu9004, createdTime=Sun Jan 18 13:53:00 CST 2015, time=2015-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103324, encodeId=bc4e2103324c3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：临床研究 经验分享：Clin Nucl Med已经上升到和Eur J Nucl Med Mol Imaging、J Nucl Med一个分段的杂志了，但不可否认的是CNM论著的质量和后两者的差距还是比较大的，尤其是和JNM比，不过CNM主打case report，其实也还好了。 杂志侧重临床研究，前瞻性和回顾性均可，临床前研究，尤其是动物实验几乎秒拒。CNM文章审稿速度比EJNMMI和JNM慢，不过整体也还行，一审50天左右，修回一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93625573977, createdName=我又不乱来, createdTime=Tue Nov 29 15:58:11 CST 2022, time=2022-11-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=960188, encodeId=d51896018886, content=这杂志20年if对半砍了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49f25135636, createdName=14665fa9m69暂无昵称, createdTime=Sun Apr 25 08:05:58 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579239, encodeId=b2e65e9239ca, content=现在自引率这么高了吗173****0520暂无昵称 2019-10-27 发表:: 后来知道了吗？173****0520暂无昵称 2019-10-27 00:00:00 发表: 后来知道了吗？, beContent=173****0520暂无昵称 2019-10-27 发表:: 后来知道了吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKeFVU0XGMYxKONpLlkGRwDrQR8jSogU9QicOBk1314ibVzicuYf8jThkRGHHhw2auib6GouZzyS1Lxw/132, createdBy=30ad2388091, createdName=夜以继日的梦想, createdTime=Sat Nov 02 00:00:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578939, encodeId=97355e8939b2, content=后来知道了吗？lanseyouyu9004 2015-01-18 13:53:00 发表: 才四天Decision in Process 什么意思呢, beContent=lanseyouyu9004 2015-01-18 13:53:00 发表: 才四天Decision in Process 什么意思呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=721b2202035, createdName=120b8a49m20暂无昵称, createdTime=Sun Oct 27 00:00:00 CST 2019, time=2019-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551041, encodeId=3167551041bf, content=没有pet的case也能在这发吗?leijiang1031_43658003 2017-12-04 发表:: SCI(2016):4.563 临床核医学非常权威的杂志leijiang1031_43658003 2017-12-04 09:45:00 发表: 临床核医学非常权威的杂志, beContent=leijiang1031_43658003 2017-12-04 发表:: SCI(2016):4.563 临床核医学非常权威的杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=949d1402322, createdName=xyxiaochang, createdTime=Tue Jan 09 00:00:00 CST 2018, time=2018-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549693, encodeId=238e549693c7, content=临床核医学非常权威的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=418, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75112214477, createdName=leijiang1031_43658003, createdTime=Mon Dec 04 09:45:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545120, encodeId=5a06545120b0, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：核医学领域算是比较老牌的杂志了吧，投Case还是比较容易的，但是CNM的论著还是很难投的；国内很多单位投CNM的case report都投烂了啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Fri Aug 04 16:55:00 CST 2017, time=2017-08-04, status=1, ipAttribution=)]

2025-01-15 ms4000001428066077 来自北京

这破杂志24年7月投的under Review 5个月没消息，第一次催稿邮件估计直接进了垃圾箱，第二次才回知道在个某个华人编辑手上，圣诞节前才给的拒稿，你猜拒稿理由人家漂亮国不用这个药而且最近有类似文章接受了？？！其他只字未提，真恶心人。。。。这杂志分数虚高都是些case，编辑不负责，建议绕道

39 0

[GetPortalCommentsPageByObjectIdResponse(id=2248196, encodeId=f050224819611, content=这破杂志24年7月投的under Review 5个月没消息，第一次催稿邮件估计直接进了垃圾箱，第二次才回知道在个某个华人编辑手上，圣诞节前才给的拒稿，你猜拒稿理由人家漂亮国不用这个药而且最近有类似文章接受了？？！其他只字未提，真恶心人。。。。这杂志分数虚高都是些case，编辑不负责，建议绕道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=618e8608174, createdName=ms4000001428066077, createdTime=Wed Jan 15 16:02:15 CST 2025, time=2025-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=902336, encodeId=bac2902336c6, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：临床;核医学 经验分享：1. 更新下准确的影像因子，杂志官网可查到，2018年为6.709，2019为6.622。 2.老牌权威的核医学杂志。 3.近几年审稿速度比较快，一般不超过1个月，算审稿速度非常快的杂志了。 4.杂志的编辑很nice，但是很严谨。case report，只要图片和病例足够新颖，可以尝试，并不太难。论著有一定难度。 5.很临床的杂志，基础的文章不太收。 5.很多case report只在CNM发表，所以自引率比别的杂志高点可以理解。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rQvUN1zHBrywpiakiasoLOFr2w6FAZpJ4k6VRQsprf74lUTXZiavoSUjuLa18Igfbrx8amqbYTJXMVHbVtJOLq3vg/132, createdBy=8bbe1657894, createdName=丹子笑, createdTime=Thu Nov 26 00:17:50 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509212, encodeId=9f5a50921228, content=审稿速度:1.0 经验分享：才四天Decision in Process 什么意思呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=caed1611946, createdName=lanseyouyu9004, createdTime=Sun Jan 18 13:53:00 CST 2015, time=2015-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103324, encodeId=bc4e2103324c3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：临床研究 经验分享：Clin Nucl Med已经上升到和Eur J Nucl Med Mol Imaging、J Nucl Med一个分段的杂志了，但不可否认的是CNM论著的质量和后两者的差距还是比较大的，尤其是和JNM比，不过CNM主打case report，其实也还好了。 杂志侧重临床研究，前瞻性和回顾性均可，临床前研究，尤其是动物实验几乎秒拒。CNM文章审稿速度比EJNMMI和JNM慢，不过整体也还行，一审50天左右，修回一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93625573977, createdName=我又不乱来, createdTime=Tue Nov 29 15:58:11 CST 2022, time=2022-11-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=960188, encodeId=d51896018886, content=这杂志20年if对半砍了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49f25135636, createdName=14665fa9m69暂无昵称, createdTime=Sun Apr 25 08:05:58 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579239, encodeId=b2e65e9239ca, content=现在自引率这么高了吗173****0520暂无昵称 2019-10-27 发表:: 后来知道了吗？173****0520暂无昵称 2019-10-27 00:00:00 发表: 后来知道了吗？, beContent=173****0520暂无昵称 2019-10-27 发表:: 后来知道了吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKeFVU0XGMYxKONpLlkGRwDrQR8jSogU9QicOBk1314ibVzicuYf8jThkRGHHhw2auib6GouZzyS1Lxw/132, createdBy=30ad2388091, createdName=夜以继日的梦想, createdTime=Sat Nov 02 00:00:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578939, encodeId=97355e8939b2, content=后来知道了吗？lanseyouyu9004 2015-01-18 13:53:00 发表: 才四天Decision in Process 什么意思呢, beContent=lanseyouyu9004 2015-01-18 13:53:00 发表: 才四天Decision in Process 什么意思呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=721b2202035, createdName=120b8a49m20暂无昵称, createdTime=Sun Oct 27 00:00:00 CST 2019, time=2019-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551041, encodeId=3167551041bf, content=没有pet的case也能在这发吗?leijiang1031_43658003 2017-12-04 发表:: SCI(2016):4.563 临床核医学非常权威的杂志leijiang1031_43658003 2017-12-04 09:45:00 发表: 临床核医学非常权威的杂志, beContent=leijiang1031_43658003 2017-12-04 发表:: SCI(2016):4.563 临床核医学非常权威的杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=949d1402322, createdName=xyxiaochang, createdTime=Tue Jan 09 00:00:00 CST 2018, time=2018-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549693, encodeId=238e549693c7, content=临床核医学非常权威的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=418, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75112214477, createdName=leijiang1031_43658003, createdTime=Mon Dec 04 09:45:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545120, encodeId=5a06545120b0, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：核医学领域算是比较老牌的杂志了吧，投Case还是比较容易的，但是CNM的论著还是很难投的；国内很多单位投CNM的case report都投烂了啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Fri Aug 04 16:55:00 CST 2017, time=2017-08-04, status=1, ipAttribution=)]

2020-11-26 丹子笑

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：临床;核医学
经验分享：1. 更新下准确的影像因子，杂志官网可查到，2018年为6.709，2019为6.622。
2.老牌权威的核医学杂志。
3.近几年审稿速度比较快，一般不超过1个月，算审稿速度非常快的杂志了。
4.杂志的编辑很nice，但是很严谨。case report，只要图片和病例足够新颖，可以尝试，并不太难。论著有一定难度。
5.很临床的杂志，基础的文章不太收。
5.很多case report只在CNM发表，所以自引率比别的杂志高点可以理解。

205 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2248196, encodeId=f050224819611, content=这破杂志24年7月投的under Review 5个月没消息，第一次催稿邮件估计直接进了垃圾箱，第二次才回知道在个某个华人编辑手上，圣诞节前才给的拒稿，你猜拒稿理由人家漂亮国不用这个药而且最近有类似文章接受了？？！其他只字未提，真恶心人。。。。这杂志分数虚高都是些case，编辑不负责，建议绕道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=618e8608174, createdName=ms4000001428066077, createdTime=Wed Jan 15 16:02:15 CST 2025, time=2025-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=902336, encodeId=bac2902336c6, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：临床;核医学 经验分享：1. 更新下准确的影像因子，杂志官网可查到，2018年为6.709，2019为6.622。 2.老牌权威的核医学杂志。 3.近几年审稿速度比较快，一般不超过1个月，算审稿速度非常快的杂志了。 4.杂志的编辑很nice，但是很严谨。case report，只要图片和病例足够新颖，可以尝试，并不太难。论著有一定难度。 5.很临床的杂志，基础的文章不太收。 5.很多case report只在CNM发表，所以自引率比别的杂志高点可以理解。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rQvUN1zHBrywpiakiasoLOFr2w6FAZpJ4k6VRQsprf74lUTXZiavoSUjuLa18Igfbrx8amqbYTJXMVHbVtJOLq3vg/132, createdBy=8bbe1657894, createdName=丹子笑, createdTime=Thu Nov 26 00:17:50 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509212, encodeId=9f5a50921228, content=审稿速度:1.0 经验分享：才四天Decision in Process 什么意思呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=caed1611946, createdName=lanseyouyu9004, createdTime=Sun Jan 18 13:53:00 CST 2015, time=2015-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103324, encodeId=bc4e2103324c3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：临床研究 经验分享：Clin Nucl Med已经上升到和Eur J Nucl Med Mol Imaging、J Nucl Med一个分段的杂志了，但不可否认的是CNM论著的质量和后两者的差距还是比较大的，尤其是和JNM比，不过CNM主打case report，其实也还好了。 杂志侧重临床研究，前瞻性和回顾性均可，临床前研究，尤其是动物实验几乎秒拒。CNM文章审稿速度比EJNMMI和JNM慢，不过整体也还行，一审50天左右，修回一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93625573977, createdName=我又不乱来, createdTime=Tue Nov 29 15:58:11 CST 2022, time=2022-11-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=960188, encodeId=d51896018886, content=这杂志20年if对半砍了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49f25135636, createdName=14665fa9m69暂无昵称, createdTime=Sun Apr 25 08:05:58 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579239, encodeId=b2e65e9239ca, content=现在自引率这么高了吗173****0520暂无昵称 2019-10-27 发表:: 后来知道了吗？173****0520暂无昵称 2019-10-27 00:00:00 发表: 后来知道了吗？, beContent=173****0520暂无昵称 2019-10-27 发表:: 后来知道了吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKeFVU0XGMYxKONpLlkGRwDrQR8jSogU9QicOBk1314ibVzicuYf8jThkRGHHhw2auib6GouZzyS1Lxw/132, createdBy=30ad2388091, createdName=夜以继日的梦想, createdTime=Sat Nov 02 00:00:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578939, encodeId=97355e8939b2, content=后来知道了吗？lanseyouyu9004 2015-01-18 13:53:00 发表: 才四天Decision in Process 什么意思呢, beContent=lanseyouyu9004 2015-01-18 13:53:00 发表: 才四天Decision in Process 什么意思呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=721b2202035, createdName=120b8a49m20暂无昵称, createdTime=Sun Oct 27 00:00:00 CST 2019, time=2019-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551041, encodeId=3167551041bf, content=没有pet的case也能在这发吗?leijiang1031_43658003 2017-12-04 发表:: SCI(2016):4.563 临床核医学非常权威的杂志leijiang1031_43658003 2017-12-04 09:45:00 发表: 临床核医学非常权威的杂志, beContent=leijiang1031_43658003 2017-12-04 发表:: SCI(2016):4.563 临床核医学非常权威的杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=949d1402322, createdName=xyxiaochang, createdTime=Tue Jan 09 00:00:00 CST 2018, time=2018-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549693, encodeId=238e549693c7, content=临床核医学非常权威的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=418, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75112214477, createdName=leijiang1031_43658003, createdTime=Mon Dec 04 09:45:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545120, encodeId=5a06545120b0, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：核医学领域算是比较老牌的杂志了吧，投Case还是比较容易的，但是CNM的论著还是很难投的；国内很多单位投CNM的case report都投烂了啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Fri Aug 04 16:55:00 CST 2017, time=2017-08-04, status=1, ipAttribution=)]

2015-01-18 lanseyouyu9004

审稿速度:1.0
经验分享：才四天Decision in Process 什么意思呢

455 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2248196, encodeId=f050224819611, content=这破杂志24年7月投的under Review 5个月没消息，第一次催稿邮件估计直接进了垃圾箱，第二次才回知道在个某个华人编辑手上，圣诞节前才给的拒稿，你猜拒稿理由人家漂亮国不用这个药而且最近有类似文章接受了？？！其他只字未提，真恶心人。。。。这杂志分数虚高都是些case，编辑不负责，建议绕道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=618e8608174, createdName=ms4000001428066077, createdTime=Wed Jan 15 16:02:15 CST 2025, time=2025-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=902336, encodeId=bac2902336c6, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：临床;核医学 经验分享：1. 更新下准确的影像因子，杂志官网可查到，2018年为6.709，2019为6.622。 2.老牌权威的核医学杂志。 3.近几年审稿速度比较快，一般不超过1个月，算审稿速度非常快的杂志了。 4.杂志的编辑很nice，但是很严谨。case report，只要图片和病例足够新颖，可以尝试，并不太难。论著有一定难度。 5.很临床的杂志，基础的文章不太收。 5.很多case report只在CNM发表，所以自引率比别的杂志高点可以理解。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rQvUN1zHBrywpiakiasoLOFr2w6FAZpJ4k6VRQsprf74lUTXZiavoSUjuLa18Igfbrx8amqbYTJXMVHbVtJOLq3vg/132, createdBy=8bbe1657894, createdName=丹子笑, createdTime=Thu Nov 26 00:17:50 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509212, encodeId=9f5a50921228, content=审稿速度:1.0 经验分享：才四天Decision in Process 什么意思呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=caed1611946, createdName=lanseyouyu9004, createdTime=Sun Jan 18 13:53:00 CST 2015, time=2015-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103324, encodeId=bc4e2103324c3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：临床研究 经验分享：Clin Nucl Med已经上升到和Eur J Nucl Med Mol Imaging、J Nucl Med一个分段的杂志了，但不可否认的是CNM论著的质量和后两者的差距还是比较大的，尤其是和JNM比，不过CNM主打case report，其实也还好了。 杂志侧重临床研究，前瞻性和回顾性均可，临床前研究，尤其是动物实验几乎秒拒。CNM文章审稿速度比EJNMMI和JNM慢，不过整体也还行，一审50天左右，修回一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93625573977, createdName=我又不乱来, createdTime=Tue Nov 29 15:58:11 CST 2022, time=2022-11-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=960188, encodeId=d51896018886, content=这杂志20年if对半砍了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49f25135636, createdName=14665fa9m69暂无昵称, createdTime=Sun Apr 25 08:05:58 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579239, encodeId=b2e65e9239ca, content=现在自引率这么高了吗173****0520暂无昵称 2019-10-27 发表:: 后来知道了吗？173****0520暂无昵称 2019-10-27 00:00:00 发表: 后来知道了吗？, beContent=173****0520暂无昵称 2019-10-27 发表:: 后来知道了吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKeFVU0XGMYxKONpLlkGRwDrQR8jSogU9QicOBk1314ibVzicuYf8jThkRGHHhw2auib6GouZzyS1Lxw/132, createdBy=30ad2388091, createdName=夜以继日的梦想, createdTime=Sat Nov 02 00:00:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578939, encodeId=97355e8939b2, content=后来知道了吗？lanseyouyu9004 2015-01-18 13:53:00 发表: 才四天Decision in Process 什么意思呢, beContent=lanseyouyu9004 2015-01-18 13:53:00 发表: 才四天Decision in Process 什么意思呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=721b2202035, createdName=120b8a49m20暂无昵称, createdTime=Sun Oct 27 00:00:00 CST 2019, time=2019-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551041, encodeId=3167551041bf, content=没有pet的case也能在这发吗?leijiang1031_43658003 2017-12-04 发表:: SCI(2016):4.563 临床核医学非常权威的杂志leijiang1031_43658003 2017-12-04 09:45:00 发表: 临床核医学非常权威的杂志, beContent=leijiang1031_43658003 2017-12-04 发表:: SCI(2016):4.563 临床核医学非常权威的杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=949d1402322, createdName=xyxiaochang, createdTime=Tue Jan 09 00:00:00 CST 2018, time=2018-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549693, encodeId=238e549693c7, content=临床核医学非常权威的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=418, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75112214477, createdName=leijiang1031_43658003, createdTime=Mon Dec 04 09:45:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545120, encodeId=5a06545120b0, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：核医学领域算是比较老牌的杂志了吧，投Case还是比较容易的，但是CNM的论著还是很难投的；国内很多单位投CNM的case report都投烂了啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Fri Aug 04 16:55:00 CST 2017, time=2017-08-04, status=1, ipAttribution=)]

2022-11-29 我又不乱来来自北京

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：临床研究
经验分享：Clin Nucl Med已经上升到和Eur J Nucl Med Mol Imaging、J Nucl Med一个分段的杂志了，但不可否认的是CNM论著的质量和后两者的差距还是比较大的，尤其是和JNM比，不过CNM主打case report，其实也还好了。
杂志侧重临床研究，前瞻性和回顾性均可，临床前研究，尤其是动物实验几乎秒拒。CNM文章审稿速度比EJNMMI和JNM慢，不过整体也还行，一审50天左右，修回一个月。

106 0

[GetPortalCommentsPageByObjectIdResponse(id=2248196, encodeId=f050224819611, content=这破杂志24年7月投的under Review 5个月没消息，第一次催稿邮件估计直接进了垃圾箱，第二次才回知道在个某个华人编辑手上，圣诞节前才给的拒稿，你猜拒稿理由人家漂亮国不用这个药而且最近有类似文章接受了？？！其他只字未提，真恶心人。。。。这杂志分数虚高都是些case，编辑不负责，建议绕道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=618e8608174, createdName=ms4000001428066077, createdTime=Wed Jan 15 16:02:15 CST 2025, time=2025-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=902336, encodeId=bac2902336c6, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：临床;核医学 经验分享：1. 更新下准确的影像因子，杂志官网可查到，2018年为6.709，2019为6.622。 2.老牌权威的核医学杂志。 3.近几年审稿速度比较快，一般不超过1个月，算审稿速度非常快的杂志了。 4.杂志的编辑很nice，但是很严谨。case report，只要图片和病例足够新颖，可以尝试，并不太难。论著有一定难度。 5.很临床的杂志，基础的文章不太收。 5.很多case report只在CNM发表，所以自引率比别的杂志高点可以理解。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rQvUN1zHBrywpiakiasoLOFr2w6FAZpJ4k6VRQsprf74lUTXZiavoSUjuLa18Igfbrx8amqbYTJXMVHbVtJOLq3vg/132, createdBy=8bbe1657894, createdName=丹子笑, createdTime=Thu Nov 26 00:17:50 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509212, encodeId=9f5a50921228, content=审稿速度:1.0 经验分享：才四天Decision in Process 什么意思呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=caed1611946, createdName=lanseyouyu9004, createdTime=Sun Jan 18 13:53:00 CST 2015, time=2015-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103324, encodeId=bc4e2103324c3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：临床研究 经验分享：Clin Nucl Med已经上升到和Eur J Nucl Med Mol Imaging、J Nucl Med一个分段的杂志了，但不可否认的是CNM论著的质量和后两者的差距还是比较大的，尤其是和JNM比，不过CNM主打case report，其实也还好了。 杂志侧重临床研究，前瞻性和回顾性均可，临床前研究，尤其是动物实验几乎秒拒。CNM文章审稿速度比EJNMMI和JNM慢，不过整体也还行，一审50天左右，修回一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93625573977, createdName=我又不乱来, createdTime=Tue Nov 29 15:58:11 CST 2022, time=2022-11-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=960188, encodeId=d51896018886, content=这杂志20年if对半砍了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49f25135636, createdName=14665fa9m69暂无昵称, createdTime=Sun Apr 25 08:05:58 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579239, encodeId=b2e65e9239ca, content=现在自引率这么高了吗173****0520暂无昵称 2019-10-27 发表:: 后来知道了吗？173****0520暂无昵称 2019-10-27 00:00:00 发表: 后来知道了吗？, beContent=173****0520暂无昵称 2019-10-27 发表:: 后来知道了吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKeFVU0XGMYxKONpLlkGRwDrQR8jSogU9QicOBk1314ibVzicuYf8jThkRGHHhw2auib6GouZzyS1Lxw/132, createdBy=30ad2388091, createdName=夜以继日的梦想, createdTime=Sat Nov 02 00:00:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578939, encodeId=97355e8939b2, content=后来知道了吗？lanseyouyu9004 2015-01-18 13:53:00 发表: 才四天Decision in Process 什么意思呢, beContent=lanseyouyu9004 2015-01-18 13:53:00 发表: 才四天Decision in Process 什么意思呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=721b2202035, createdName=120b8a49m20暂无昵称, createdTime=Sun Oct 27 00:00:00 CST 2019, time=2019-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551041, encodeId=3167551041bf, content=没有pet的case也能在这发吗?leijiang1031_43658003 2017-12-04 发表:: SCI(2016):4.563 临床核医学非常权威的杂志leijiang1031_43658003 2017-12-04 09:45:00 发表: 临床核医学非常权威的杂志, beContent=leijiang1031_43658003 2017-12-04 发表:: SCI(2016):4.563 临床核医学非常权威的杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=949d1402322, createdName=xyxiaochang, createdTime=Tue Jan 09 00:00:00 CST 2018, time=2018-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549693, encodeId=238e549693c7, content=临床核医学非常权威的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=418, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75112214477, createdName=leijiang1031_43658003, createdTime=Mon Dec 04 09:45:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545120, encodeId=5a06545120b0, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：核医学领域算是比较老牌的杂志了吧，投Case还是比较容易的，但是CNM的论著还是很难投的；国内很多单位投CNM的case report都投烂了啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Fri Aug 04 16:55:00 CST 2017, time=2017-08-04, status=1, ipAttribution=)]

2021-04-25 14665fa9m69暂无昵称

这杂志20年if对半砍了？？？

132 0

[GetPortalCommentsPageByObjectIdResponse(id=2248196, encodeId=f050224819611, content=这破杂志24年7月投的under Review 5个月没消息，第一次催稿邮件估计直接进了垃圾箱，第二次才回知道在个某个华人编辑手上，圣诞节前才给的拒稿，你猜拒稿理由人家漂亮国不用这个药而且最近有类似文章接受了？？！其他只字未提，真恶心人。。。。这杂志分数虚高都是些case，编辑不负责，建议绕道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=618e8608174, createdName=ms4000001428066077, createdTime=Wed Jan 15 16:02:15 CST 2025, time=2025-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=902336, encodeId=bac2902336c6, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：临床;核医学 经验分享：1. 更新下准确的影像因子，杂志官网可查到，2018年为6.709，2019为6.622。 2.老牌权威的核医学杂志。 3.近几年审稿速度比较快，一般不超过1个月，算审稿速度非常快的杂志了。 4.杂志的编辑很nice，但是很严谨。case report，只要图片和病例足够新颖，可以尝试，并不太难。论著有一定难度。 5.很临床的杂志，基础的文章不太收。 5.很多case report只在CNM发表，所以自引率比别的杂志高点可以理解。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rQvUN1zHBrywpiakiasoLOFr2w6FAZpJ4k6VRQsprf74lUTXZiavoSUjuLa18Igfbrx8amqbYTJXMVHbVtJOLq3vg/132, createdBy=8bbe1657894, createdName=丹子笑, createdTime=Thu Nov 26 00:17:50 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509212, encodeId=9f5a50921228, content=审稿速度:1.0 经验分享：才四天Decision in Process 什么意思呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=caed1611946, createdName=lanseyouyu9004, createdTime=Sun Jan 18 13:53:00 CST 2015, time=2015-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103324, encodeId=bc4e2103324c3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：临床研究 经验分享：Clin Nucl Med已经上升到和Eur J Nucl Med Mol Imaging、J Nucl Med一个分段的杂志了，但不可否认的是CNM论著的质量和后两者的差距还是比较大的，尤其是和JNM比，不过CNM主打case report，其实也还好了。 杂志侧重临床研究，前瞻性和回顾性均可，临床前研究，尤其是动物实验几乎秒拒。CNM文章审稿速度比EJNMMI和JNM慢，不过整体也还行，一审50天左右，修回一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93625573977, createdName=我又不乱来, createdTime=Tue Nov 29 15:58:11 CST 2022, time=2022-11-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=960188, encodeId=d51896018886, content=这杂志20年if对半砍了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49f25135636, createdName=14665fa9m69暂无昵称, createdTime=Sun Apr 25 08:05:58 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579239, encodeId=b2e65e9239ca, content=现在自引率这么高了吗173****0520暂无昵称 2019-10-27 发表:: 后来知道了吗？173****0520暂无昵称 2019-10-27 00:00:00 发表: 后来知道了吗？, beContent=173****0520暂无昵称 2019-10-27 发表:: 后来知道了吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKeFVU0XGMYxKONpLlkGRwDrQR8jSogU9QicOBk1314ibVzicuYf8jThkRGHHhw2auib6GouZzyS1Lxw/132, createdBy=30ad2388091, createdName=夜以继日的梦想, createdTime=Sat Nov 02 00:00:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578939, encodeId=97355e8939b2, content=后来知道了吗？lanseyouyu9004 2015-01-18 13:53:00 发表: 才四天Decision in Process 什么意思呢, beContent=lanseyouyu9004 2015-01-18 13:53:00 发表: 才四天Decision in Process 什么意思呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=721b2202035, createdName=120b8a49m20暂无昵称, createdTime=Sun Oct 27 00:00:00 CST 2019, time=2019-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551041, encodeId=3167551041bf, content=没有pet的case也能在这发吗?leijiang1031_43658003 2017-12-04 发表:: SCI(2016):4.563 临床核医学非常权威的杂志leijiang1031_43658003 2017-12-04 09:45:00 发表: 临床核医学非常权威的杂志, beContent=leijiang1031_43658003 2017-12-04 发表:: SCI(2016):4.563 临床核医学非常权威的杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=949d1402322, createdName=xyxiaochang, createdTime=Tue Jan 09 00:00:00 CST 2018, time=2018-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549693, encodeId=238e549693c7, content=临床核医学非常权威的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=418, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75112214477, createdName=leijiang1031_43658003, createdTime=Mon Dec 04 09:45:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545120, encodeId=5a06545120b0, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：核医学领域算是比较老牌的杂志了吧，投Case还是比较容易的，但是CNM的论著还是很难投的；国内很多单位投CNM的case report都投烂了啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Fri Aug 04 16:55:00 CST 2017, time=2017-08-04, status=1, ipAttribution=)]

2019-11-02 夜以继日的梦想

现在自引率这么高了吗173****0520暂无昵称 2019-10-27 发表::
后来知道了吗？173****0520暂无昵称 2019-10-27 00:00:00 发表:
后来知道了吗？

173****0520暂无昵称 2019-10-27 发表:: 后来知道了吗？

229 0

[GetPortalCommentsPageByObjectIdResponse(id=2248196, encodeId=f050224819611, content=这破杂志24年7月投的under Review 5个月没消息，第一次催稿邮件估计直接进了垃圾箱，第二次才回知道在个某个华人编辑手上，圣诞节前才给的拒稿，你猜拒稿理由人家漂亮国不用这个药而且最近有类似文章接受了？？！其他只字未提，真恶心人。。。。这杂志分数虚高都是些case，编辑不负责，建议绕道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=618e8608174, createdName=ms4000001428066077, createdTime=Wed Jan 15 16:02:15 CST 2025, time=2025-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=902336, encodeId=bac2902336c6, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：临床;核医学 经验分享：1. 更新下准确的影像因子，杂志官网可查到，2018年为6.709，2019为6.622。 2.老牌权威的核医学杂志。 3.近几年审稿速度比较快，一般不超过1个月，算审稿速度非常快的杂志了。 4.杂志的编辑很nice，但是很严谨。case report，只要图片和病例足够新颖，可以尝试，并不太难。论著有一定难度。 5.很临床的杂志，基础的文章不太收。 5.很多case report只在CNM发表，所以自引率比别的杂志高点可以理解。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rQvUN1zHBrywpiakiasoLOFr2w6FAZpJ4k6VRQsprf74lUTXZiavoSUjuLa18Igfbrx8amqbYTJXMVHbVtJOLq3vg/132, createdBy=8bbe1657894, createdName=丹子笑, createdTime=Thu Nov 26 00:17:50 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509212, encodeId=9f5a50921228, content=审稿速度:1.0 经验分享：才四天Decision in Process 什么意思呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=caed1611946, createdName=lanseyouyu9004, createdTime=Sun Jan 18 13:53:00 CST 2015, time=2015-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103324, encodeId=bc4e2103324c3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：临床研究 经验分享：Clin Nucl Med已经上升到和Eur J Nucl Med Mol Imaging、J Nucl Med一个分段的杂志了，但不可否认的是CNM论著的质量和后两者的差距还是比较大的，尤其是和JNM比，不过CNM主打case report，其实也还好了。 杂志侧重临床研究，前瞻性和回顾性均可，临床前研究，尤其是动物实验几乎秒拒。CNM文章审稿速度比EJNMMI和JNM慢，不过整体也还行，一审50天左右，修回一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93625573977, createdName=我又不乱来, createdTime=Tue Nov 29 15:58:11 CST 2022, time=2022-11-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=960188, encodeId=d51896018886, content=这杂志20年if对半砍了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49f25135636, createdName=14665fa9m69暂无昵称, createdTime=Sun Apr 25 08:05:58 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579239, encodeId=b2e65e9239ca, content=现在自引率这么高了吗173****0520暂无昵称 2019-10-27 发表:: 后来知道了吗？173****0520暂无昵称 2019-10-27 00:00:00 发表: 后来知道了吗？, beContent=173****0520暂无昵称 2019-10-27 发表:: 后来知道了吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKeFVU0XGMYxKONpLlkGRwDrQR8jSogU9QicOBk1314ibVzicuYf8jThkRGHHhw2auib6GouZzyS1Lxw/132, createdBy=30ad2388091, createdName=夜以继日的梦想, createdTime=Sat Nov 02 00:00:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578939, encodeId=97355e8939b2, content=后来知道了吗？lanseyouyu9004 2015-01-18 13:53:00 发表: 才四天Decision in Process 什么意思呢, beContent=lanseyouyu9004 2015-01-18 13:53:00 发表: 才四天Decision in Process 什么意思呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=721b2202035, createdName=120b8a49m20暂无昵称, createdTime=Sun Oct 27 00:00:00 CST 2019, time=2019-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551041, encodeId=3167551041bf, content=没有pet的case也能在这发吗?leijiang1031_43658003 2017-12-04 发表:: SCI(2016):4.563 临床核医学非常权威的杂志leijiang1031_43658003 2017-12-04 09:45:00 发表: 临床核医学非常权威的杂志, beContent=leijiang1031_43658003 2017-12-04 发表:: SCI(2016):4.563 临床核医学非常权威的杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=949d1402322, createdName=xyxiaochang, createdTime=Tue Jan 09 00:00:00 CST 2018, time=2018-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549693, encodeId=238e549693c7, content=临床核医学非常权威的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=418, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75112214477, createdName=leijiang1031_43658003, createdTime=Mon Dec 04 09:45:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545120, encodeId=5a06545120b0, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：核医学领域算是比较老牌的杂志了吧，投Case还是比较容易的，但是CNM的论著还是很难投的；国内很多单位投CNM的case report都投烂了啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Fri Aug 04 16:55:00 CST 2017, time=2017-08-04, status=1, ipAttribution=)]

2019-10-27 120b8a49m20暂无昵称

后来知道了吗？lanseyouyu9004 2015-01-18 13:53:00 发表:
才四天Decision in Process 什么意思呢

lanseyouyu9004 2015-01-18 13:53:00 发表: 才四天Decision in Process 什么意思呢

242 0

[GetPortalCommentsPageByObjectIdResponse(id=2248196, encodeId=f050224819611, content=这破杂志24年7月投的under Review 5个月没消息，第一次催稿邮件估计直接进了垃圾箱，第二次才回知道在个某个华人编辑手上，圣诞节前才给的拒稿，你猜拒稿理由人家漂亮国不用这个药而且最近有类似文章接受了？？！其他只字未提，真恶心人。。。。这杂志分数虚高都是些case，编辑不负责，建议绕道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=618e8608174, createdName=ms4000001428066077, createdTime=Wed Jan 15 16:02:15 CST 2025, time=2025-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=902336, encodeId=bac2902336c6, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：临床;核医学 经验分享：1. 更新下准确的影像因子，杂志官网可查到，2018年为6.709，2019为6.622。 2.老牌权威的核医学杂志。 3.近几年审稿速度比较快，一般不超过1个月，算审稿速度非常快的杂志了。 4.杂志的编辑很nice，但是很严谨。case report，只要图片和病例足够新颖，可以尝试，并不太难。论著有一定难度。 5.很临床的杂志，基础的文章不太收。 5.很多case report只在CNM发表，所以自引率比别的杂志高点可以理解。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rQvUN1zHBrywpiakiasoLOFr2w6FAZpJ4k6VRQsprf74lUTXZiavoSUjuLa18Igfbrx8amqbYTJXMVHbVtJOLq3vg/132, createdBy=8bbe1657894, createdName=丹子笑, createdTime=Thu Nov 26 00:17:50 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509212, encodeId=9f5a50921228, content=审稿速度:1.0 经验分享：才四天Decision in Process 什么意思呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=caed1611946, createdName=lanseyouyu9004, createdTime=Sun Jan 18 13:53:00 CST 2015, time=2015-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103324, encodeId=bc4e2103324c3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：临床研究 经验分享：Clin Nucl Med已经上升到和Eur J Nucl Med Mol Imaging、J Nucl Med一个分段的杂志了，但不可否认的是CNM论著的质量和后两者的差距还是比较大的，尤其是和JNM比，不过CNM主打case report，其实也还好了。 杂志侧重临床研究，前瞻性和回顾性均可，临床前研究，尤其是动物实验几乎秒拒。CNM文章审稿速度比EJNMMI和JNM慢，不过整体也还行，一审50天左右，修回一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93625573977, createdName=我又不乱来, createdTime=Tue Nov 29 15:58:11 CST 2022, time=2022-11-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=960188, encodeId=d51896018886, content=这杂志20年if对半砍了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49f25135636, createdName=14665fa9m69暂无昵称, createdTime=Sun Apr 25 08:05:58 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579239, encodeId=b2e65e9239ca, content=现在自引率这么高了吗173****0520暂无昵称 2019-10-27 发表:: 后来知道了吗？173****0520暂无昵称 2019-10-27 00:00:00 发表: 后来知道了吗？, beContent=173****0520暂无昵称 2019-10-27 发表:: 后来知道了吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKeFVU0XGMYxKONpLlkGRwDrQR8jSogU9QicOBk1314ibVzicuYf8jThkRGHHhw2auib6GouZzyS1Lxw/132, createdBy=30ad2388091, createdName=夜以继日的梦想, createdTime=Sat Nov 02 00:00:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578939, encodeId=97355e8939b2, content=后来知道了吗？lanseyouyu9004 2015-01-18 13:53:00 发表: 才四天Decision in Process 什么意思呢, beContent=lanseyouyu9004 2015-01-18 13:53:00 发表: 才四天Decision in Process 什么意思呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=721b2202035, createdName=120b8a49m20暂无昵称, createdTime=Sun Oct 27 00:00:00 CST 2019, time=2019-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551041, encodeId=3167551041bf, content=没有pet的case也能在这发吗?leijiang1031_43658003 2017-12-04 发表:: SCI(2016):4.563 临床核医学非常权威的杂志leijiang1031_43658003 2017-12-04 09:45:00 发表: 临床核医学非常权威的杂志, beContent=leijiang1031_43658003 2017-12-04 发表:: SCI(2016):4.563 临床核医学非常权威的杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=949d1402322, createdName=xyxiaochang, createdTime=Tue Jan 09 00:00:00 CST 2018, time=2018-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549693, encodeId=238e549693c7, content=临床核医学非常权威的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=418, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75112214477, createdName=leijiang1031_43658003, createdTime=Mon Dec 04 09:45:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545120, encodeId=5a06545120b0, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：核医学领域算是比较老牌的杂志了吧，投Case还是比较容易的，但是CNM的论著还是很难投的；国内很多单位投CNM的case report都投烂了啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Fri Aug 04 16:55:00 CST 2017, time=2017-08-04, status=1, ipAttribution=)]

2018-01-09 xyxiaochang

没有pet的case也能在这发吗?leijiang1031_43658003 2017-12-04 发表::
SCI(2016):4.563 临床核医学非常权威的杂志leijiang1031_43658003 2017-12-04 09:45:00 发表:
临床核医学非常权威的杂志

leijiang1031_43658003 2017-12-04 发表:: SCI(2016):4.563 临床核医学非常权威的杂志

375 0

[GetPortalCommentsPageByObjectIdResponse(id=2248196, encodeId=f050224819611, content=这破杂志24年7月投的under Review 5个月没消息，第一次催稿邮件估计直接进了垃圾箱，第二次才回知道在个某个华人编辑手上，圣诞节前才给的拒稿，你猜拒稿理由人家漂亮国不用这个药而且最近有类似文章接受了？？！其他只字未提，真恶心人。。。。这杂志分数虚高都是些case，编辑不负责，建议绕道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=618e8608174, createdName=ms4000001428066077, createdTime=Wed Jan 15 16:02:15 CST 2025, time=2025-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=902336, encodeId=bac2902336c6, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：临床;核医学 经验分享：1. 更新下准确的影像因子，杂志官网可查到，2018年为6.709，2019为6.622。 2.老牌权威的核医学杂志。 3.近几年审稿速度比较快，一般不超过1个月，算审稿速度非常快的杂志了。 4.杂志的编辑很nice，但是很严谨。case report，只要图片和病例足够新颖，可以尝试，并不太难。论著有一定难度。 5.很临床的杂志，基础的文章不太收。 5.很多case report只在CNM发表，所以自引率比别的杂志高点可以理解。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rQvUN1zHBrywpiakiasoLOFr2w6FAZpJ4k6VRQsprf74lUTXZiavoSUjuLa18Igfbrx8amqbYTJXMVHbVtJOLq3vg/132, createdBy=8bbe1657894, createdName=丹子笑, createdTime=Thu Nov 26 00:17:50 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509212, encodeId=9f5a50921228, content=审稿速度:1.0 经验分享：才四天Decision in Process 什么意思呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=caed1611946, createdName=lanseyouyu9004, createdTime=Sun Jan 18 13:53:00 CST 2015, time=2015-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103324, encodeId=bc4e2103324c3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：临床研究 经验分享：Clin Nucl Med已经上升到和Eur J Nucl Med Mol Imaging、J Nucl Med一个分段的杂志了，但不可否认的是CNM论著的质量和后两者的差距还是比较大的，尤其是和JNM比，不过CNM主打case report，其实也还好了。 杂志侧重临床研究，前瞻性和回顾性均可，临床前研究，尤其是动物实验几乎秒拒。CNM文章审稿速度比EJNMMI和JNM慢，不过整体也还行，一审50天左右，修回一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93625573977, createdName=我又不乱来, createdTime=Tue Nov 29 15:58:11 CST 2022, time=2022-11-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=960188, encodeId=d51896018886, content=这杂志20年if对半砍了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49f25135636, createdName=14665fa9m69暂无昵称, createdTime=Sun Apr 25 08:05:58 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579239, encodeId=b2e65e9239ca, content=现在自引率这么高了吗173****0520暂无昵称 2019-10-27 发表:: 后来知道了吗？173****0520暂无昵称 2019-10-27 00:00:00 发表: 后来知道了吗？, beContent=173****0520暂无昵称 2019-10-27 发表:: 后来知道了吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKeFVU0XGMYxKONpLlkGRwDrQR8jSogU9QicOBk1314ibVzicuYf8jThkRGHHhw2auib6GouZzyS1Lxw/132, createdBy=30ad2388091, createdName=夜以继日的梦想, createdTime=Sat Nov 02 00:00:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578939, encodeId=97355e8939b2, content=后来知道了吗？lanseyouyu9004 2015-01-18 13:53:00 发表: 才四天Decision in Process 什么意思呢, beContent=lanseyouyu9004 2015-01-18 13:53:00 发表: 才四天Decision in Process 什么意思呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=721b2202035, createdName=120b8a49m20暂无昵称, createdTime=Sun Oct 27 00:00:00 CST 2019, time=2019-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551041, encodeId=3167551041bf, content=没有pet的case也能在这发吗?leijiang1031_43658003 2017-12-04 发表:: SCI(2016):4.563 临床核医学非常权威的杂志leijiang1031_43658003 2017-12-04 09:45:00 发表: 临床核医学非常权威的杂志, beContent=leijiang1031_43658003 2017-12-04 发表:: SCI(2016):4.563 临床核医学非常权威的杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=949d1402322, createdName=xyxiaochang, createdTime=Tue Jan 09 00:00:00 CST 2018, time=2018-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549693, encodeId=238e549693c7, content=临床核医学非常权威的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=418, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75112214477, createdName=leijiang1031_43658003, createdTime=Mon Dec 04 09:45:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545120, encodeId=5a06545120b0, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：核医学领域算是比较老牌的杂志了吧，投Case还是比较容易的，但是CNM的论著还是很难投的；国内很多单位投CNM的case report都投烂了啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Fri Aug 04 16:55:00 CST 2017, time=2017-08-04, status=1, ipAttribution=)]

2017-12-04 leijiang1031_43658003

临床核医学非常权威的杂志

418 0

[GetPortalCommentsPageByObjectIdResponse(id=2248196, encodeId=f050224819611, content=这破杂志24年7月投的under Review 5个月没消息，第一次催稿邮件估计直接进了垃圾箱，第二次才回知道在个某个华人编辑手上，圣诞节前才给的拒稿，你猜拒稿理由人家漂亮国不用这个药而且最近有类似文章接受了？？！其他只字未提，真恶心人。。。。这杂志分数虚高都是些case，编辑不负责，建议绕道, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=618e8608174, createdName=ms4000001428066077, createdTime=Wed Jan 15 16:02:15 CST 2025, time=2025-01-15, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=902336, encodeId=bac2902336c6, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：临床;核医学 经验分享：1. 更新下准确的影像因子，杂志官网可查到，2018年为6.709，2019为6.622。 2.老牌权威的核医学杂志。 3.近几年审稿速度比较快，一般不超过1个月，算审稿速度非常快的杂志了。 4.杂志的编辑很nice，但是很严谨。case report，只要图片和病例足够新颖，可以尝试，并不太难。论著有一定难度。 5.很临床的杂志，基础的文章不太收。 5.很多case report只在CNM发表，所以自引率比别的杂志高点可以理解。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=205, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/rQvUN1zHBrywpiakiasoLOFr2w6FAZpJ4k6VRQsprf74lUTXZiavoSUjuLa18Igfbrx8amqbYTJXMVHbVtJOLq3vg/132, createdBy=8bbe1657894, createdName=丹子笑, createdTime=Thu Nov 26 00:17:50 CST 2020, time=2020-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509212, encodeId=9f5a50921228, content=审稿速度:1.0 经验分享：才四天Decision in Process 什么意思呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=455, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=caed1611946, createdName=lanseyouyu9004, createdTime=Sun Jan 18 13:53:00 CST 2015, time=2015-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2103324, encodeId=bc4e2103324c3, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：临床研究 经验分享：Clin Nucl Med已经上升到和Eur J Nucl Med Mol Imaging、J Nucl Med一个分段的杂志了，但不可否认的是CNM论著的质量和后两者的差距还是比较大的，尤其是和JNM比，不过CNM主打case report，其实也还好了。 杂志侧重临床研究，前瞻性和回顾性均可，临床前研究，尤其是动物实验几乎秒拒。CNM文章审稿速度比EJNMMI和JNM慢，不过整体也还行，一审50天左右，修回一个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=93625573977, createdName=我又不乱来, createdTime=Tue Nov 29 15:58:11 CST 2022, time=2022-11-29, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=960188, encodeId=d51896018886, content=这杂志20年if对半砍了？？？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49f25135636, createdName=14665fa9m69暂无昵称, createdTime=Sun Apr 25 08:05:58 CST 2021, time=2021-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579239, encodeId=b2e65e9239ca, content=现在自引率这么高了吗173****0520暂无昵称 2019-10-27 发表:: 后来知道了吗？173****0520暂无昵称 2019-10-27 00:00:00 发表: 后来知道了吗？, beContent=173****0520暂无昵称 2019-10-27 发表:: 后来知道了吗？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqKeFVU0XGMYxKONpLlkGRwDrQR8jSogU9QicOBk1314ibVzicuYf8jThkRGHHhw2auib6GouZzyS1Lxw/132, createdBy=30ad2388091, createdName=夜以继日的梦想, createdTime=Sat Nov 02 00:00:00 CST 2019, time=2019-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578939, encodeId=97355e8939b2, content=后来知道了吗？lanseyouyu9004 2015-01-18 13:53:00 发表: 才四天Decision in Process 什么意思呢, beContent=lanseyouyu9004 2015-01-18 13:53:00 发表: 才四天Decision in Process 什么意思呢, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=721b2202035, createdName=120b8a49m20暂无昵称, createdTime=Sun Oct 27 00:00:00 CST 2019, time=2019-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=551041, encodeId=3167551041bf, content=没有pet的case也能在这发吗?leijiang1031_43658003 2017-12-04 发表:: SCI(2016):4.563 临床核医学非常权威的杂志leijiang1031_43658003 2017-12-04 09:45:00 发表: 临床核医学非常权威的杂志, beContent=leijiang1031_43658003 2017-12-04 发表:: SCI(2016):4.563 临床核医学非常权威的杂志, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=949d1402322, createdName=xyxiaochang, createdTime=Tue Jan 09 00:00:00 CST 2018, time=2018-01-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549693, encodeId=238e549693c7, content=临床核医学非常权威的杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=418, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=75112214477, createdName=leijiang1031_43658003, createdTime=Mon Dec 04 09:45:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545120, encodeId=5a06545120b0, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：核医学领域算是比较老牌的杂志了吧，投Case还是比较容易的，但是CNM的论著还是很难投的；国内很多单位投CNM的case report都投烂了啊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=334, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160620/IMG5767F7B4941608075.jpg, createdBy=16081612750, createdName=nnnuclear, createdTime=Fri Aug 04 16:55:00 CST 2017, time=2017-08-04, status=1, ipAttribution=)]

2017-08-04 nnnuclear

审稿速度:1.0 | 投稿命中率:50.0
经验分享：核医学领域算是比较老牌的杂志了吧，投Case还是比较容易的，但是CNM的论著还是很难投的；国内很多单位投CNM的case report都投烂了啊。

334 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务